Transcription of Recommendations of the Advisory Committee on …
{{id}} {{{paragraph}}}
Morbidity and Mortality Weekly ReportMMWR / January 26, 2018 / Vol. 67 / No. 3 103US Department of Health and Human Services/Centers for disease control and PreventionRecommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster VaccinesKathleen L. Dooling, MD1; Angela Guo, MPH1; Manisha Patel, MD1; Grace M. Lee, MD2; Kelly Moore, MD3; Edward A. Belongia, MD4; Rafael Harpaz, MD1 IntroductionOn October 20, 2017, Zoster Vaccine Recombinant, Adjuvanted (Shingrix, GlaxoSmithKline, [GSK] Research Triangle Park, North Carolina), a 2-dose, subunit vaccine containing recombinant glycoprotein E in combination with a novel adjuvant (AS01B), was approved by the Food and Drug Administration for the prevention of herpes zoster in adults aged 50 years.
Morbidity and Mortality Weekly Report US Department of Health and Human Services/Centers for Disease Control and Prevention MMWR / January 26, 2018 / …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Example audit committee charter - EY, Example audit committee charter, Committee, Audit committee reporting to shareholders, Fraud and Responsibilities of Audit Committee, Vaccine safety, Pastor, Staff, & Committee Job Description Book, STEERING COMMITTEE & INTERGROUP, Provisional calendar of fao/ifad, Wfp governing bodies and other